Purchases and Sales Made in Q4 2023 in Entera Bio Ltd. (ENTX)
This table provides information about the institutional ownership of Entera Bio Ltd. (ENTX) during Q4 2023. The information is specifically focused on institutions that hold shares of Entera Bio Ltd..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2024
Q4 2023
|
Knoll Capital Management, LLC
Miami, FL |
BUY
|
- |
1.4M+ 56.26% |
$769K - $1.03M
|
3.88M
$8.77M
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
69.4KNew |
$38.2K - $51.4K
|
69.4K
$157K
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
34K+ 145.3% |
$18.7K - $25.2K
|
57.4K
$130K
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
10.1KNew |
$5.55K - $7.47K
|
10.1K
$22.8K
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
1KNew |
$550 - $740
|
1K
$2.26K
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
200New |
$110 - $148
|
200
$452
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|